- Home
- FVRR vs ARVN Comparison
FVRR vs ARVN Comparison
Compare FVRR & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FVRR
- ARVN
- Stock Information
- Founded
- FVRR 2010
- ARVN 2015
- Country
- FVRR Israel
- ARVN United States
- Employees
- FVRR N/A
- ARVN N/A
- Industry
- FVRR Business Services
- ARVN Biotechnology: Pharmaceutical Preparations
- Sector
- FVRR Consumer Discretionary
- ARVN Health Care
- Exchange
- FVRR Nasdaq
- ARVN Nasdaq
- Market Cap
- FVRR 827.3M
- ARVN 676.2M
- IPO Year
- FVRR 2019
- ARVN 2018
- Fundamental
- Price
- FVRR $21.67
- ARVN $10.59
- Analyst Decision
- FVRR Strong Buy
- ARVN Buy
- Analyst Count
- FVRR 10
- ARVN 23
- Target Price
- FVRR $32.60
- ARVN $17.80
- AVG Volume (30 Days)
- FVRR 833.7K
- ARVN 2.2M
- Earning Date
- FVRR 11-05-2025
- ARVN 11-05-2025
- Dividend Yield
- FVRR N/A
- ARVN N/A
- EPS Growth
- FVRR 139.40
- ARVN N/A
- EPS
- FVRR 0.61
- ARVN N/A
- Revenue
- FVRR $427,401,000.00
- ARVN $312,300,000.00
- Revenue This Year
- FVRR $12.80
- ARVN N/A
- Revenue Next Year
- FVRR $6.58
- ARVN N/A
- P/E Ratio
- FVRR $36.88
- ARVN N/A
- Revenue Growth
- FVRR 12.68
- ARVN 93.86
- 52 Week Low
- FVRR $19.69
- ARVN $5.90
- 52 Week High
- FVRR $36.11
- ARVN $27.00
- Technical
- Relative Strength Index (RSI)
- FVRR 44.94
- ARVN 59.44
- Support Level
- FVRR $21.38
- ARVN $9.27
- Resistance Level
- FVRR $22.70
- ARVN $11.51
- Average True Range (ATR)
- FVRR 0.94
- ARVN 0.53
- MACD
- FVRR 0.06
- ARVN 0.02
- Stochastic Oscillator
- FVRR 48.50
- ARVN 59.15
About FVRR Fiverr International Ltd. no par value
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Wiring and Translation, and Video and Animation among others.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.